HIV-1 Qualitative Nucleic Acid Test (NAT) – Plasma

What This Test Measures

The HIV-1 Qualitative Nucleic Acid Test (NAT) looks for the presence of HIV-1 genetic material (RNA) in your plasma. NAT is highly sensitive and can detect HIV-1 earlier than traditional antibody tests, often within weeks of infection. This test is typically used as part of initial screening or confirmation when other tests suggest possible HIV exposure.

How the Test Works

The test uses a specialized probe to identify specific sequences of HIV-1 RNA. If HIV-1 is present, the probe binds to its genetic material, allowing for detection. This method is highly accurate and can detect very low levels of the virus.

When This Test Is Ordered

A NAT test for HIV-1 is often recommended in the following situations: after potential exposure to HIV (e.g., unprotected sex, needle sharing), during early stages of infection when symptoms may not yet appear, or as part of routine screening for people at higher risk. It may also be used to confirm HIV status in cases where antibody tests are inconclusive.

Sample Collection and Preparation

For this test, a blood sample is drawn from a vein, and the plasma portion is separated for testing. Plasma is the liquid component of blood that contains the virus if present. The sample is then processed and analyzed in a laboratory using advanced molecular techniques.